(Q38705312)

5 September 2017

1 reference

title

Immunobiology of the HIV envelope (English)

1 reference

5 September 2017

1

Bolognesi DP

1 reference

5 September 2017

language of work or name

English

0 references

publication date

1 January 1989

1 reference

Annals of the New York Academy of Sciences

5 September 2017

published in

1 reference

5 September 2017

volume

567

1 reference

5 September 2017

page(s)

69-81

1 reference

A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

HIV infection is blocked in vitro by recombinant soluble CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

A soluble form of CD4 (T4) protein inhibits AIDS virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Evidence for the direct involvement of the rhinovirus canyon in receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Antibody-dependent enhancement of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Sequence homology between acquired immunodeficiency syndrome virus envelope protein and interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Functional interaction and partial homology between human immunodeficiency virus and neuroleukin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Loss of envelope antigens of HTLV-III/LAV, a factor in AIDS pathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

T cells can present antigens such as HIV gp120 targeted to their own surface molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

A soluble CD4 protein selectively inhibits HIV replication and syncytium formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB16460.X

10.1111/J.1749-6632.1989.TB16460.X

21 January 2018

Identifiers

DOI

1 reference

5 September 2017

1 reference